B. Torres

发表

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

D. Podzamczer, B. Clotet, A. Winston, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment

E. Gratacós, F. Crispi, O. Gómez, 2019, PloS one.

Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial

M. Plana, M. Squarcia, L. Leal, 2021, HIV medicine.

Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients

Felipe García, M. Plana, M. Arnedo, 2015, AIDS.

Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study

Felipe García, J. Miro, J. Mallolas, 2020, AIDS.

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study

Á. Soriano, J. Mallolas, M. Laguno, 2022, Infectious Diseases and Therapy.

Long term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in HCV-HIV coinfected patients.

J. Mallolas, E. Martinez, J. Blanco, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Á. Soriano, J. Mallolas, M. Laguno, 2022, Infection.

Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome

Á. Soriano, J. Miro, J. Mallolas, 2020, International Journal of Infectious Diseases.

Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

L. Miquel, J. Blanch, J. Mallolas, 2022, Infectious Diseases and Therapy.

PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia

Felipe García, M. Plana, A. Meyerhans, 2015, PLoS pathogens.

Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression.

J. Gatell, J. Mallolas, E. Martinez, 2016, The Journal of antimicrobial chemotherapy.

Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study

X. Forns, J. Blanch, J. Mallolas, 2021, Infectious Diseases and Therapy.

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Miguel Ángel Martínez, D. Podzamczer, J. Mallolas, 2021, The Lancet HIV.

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Felipe García, Á. Soriano, J. Nicolás, 2020, Clinical Microbiology and Infection.

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Roger Paredes, Esteban Martinez, Bonaventura Clotet, 2018, The Journal of antimicrobial chemotherapy.

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.

Felipe García, A. León, J. Mallolas, 2016, The Journal of antimicrobial chemotherapy.

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data

Á. Soriano, J. Mallolas, J. Blanco, 2021, Infectious Diseases and Therapy.

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

A. Cruceta, J. Miro, A. León, 2017, The Journal of antimicrobial chemotherapy.

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.

Felipe García, A. León, J. Mallolas, 2016, The Journal of antimicrobial chemotherapy.

Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis

Á. Soriano, C. Fehér, F. Marco, 2017, The Journal of antimicrobial chemotherapy.

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response

Felipe García, C. Fehér, L. Leal, 2020, Vaccines.

Overview of SARS-CoV-2 infection in adults living with HIV

Á. Soriano, J. Miro, J. Mallolas, 2021, The Lancet HIV.

Tocilizumab is associated with reduction of the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, J. Nicolás, 2020, medRxiv.

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses

M. Plana, M. Esteban, B. Perdiguero, 2023, Vaccines.

Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.

M. Muñoz-Fernández, S. Jiménez de Ory, J. Bellón, 2020, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial.

B. Clotet, E. Negredo, Felipe García, 2014, AIDS research and human retroviruses.

Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain

L. Miquel, J. Blanch, J. Mallolas, 2022, AIDS and Behavior.

Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study

L. Miquel, J. Blanch, J. Mallolas, 2022, Sexuality Research and Social Policy.

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation

Felipe García, M. Plana, J. Gatell, 2014, Journal of the International AIDS Society.

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience

J. Mallolas, J. Blanco, M. Laguno, 2022, Infectious Diseases and Therapy.

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.

J. Mallolas, E. Martinez, J. Blanco, 2021, Enfermedades infecciosas y microbiologia clinica.

Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis.

J. Mallolas, M. Górgolas, A. Cabello, 2020, Gastroenterologia y hepatologia.

Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis

J. Mallolas, M. Górgolas, A. Cabello, 2022, Gastroenterología y Hepatología (English Edition).

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020

E. Fernández, J. Mallolas, J. Blanco, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19

Á. Soriano, J. Mallolas, M. Laguno, 2022, Scientific Reports.

[Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients].

J. Gatell, J. Mallolas, E. Martinez, 2015, Enfermedades infecciosas y microbiologia clinica.

Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

Felipe García, M. Plana, M. Arnedo, 2013, AIDS research and human retroviruses.

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study

Á. Soriano, M. Laguno, I. Alobid, 2021, BMJ Open.

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

D. Podzamczer, J. Blanco, M. Laguno, 2020, Clinical Microbiology and Infection.

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

A. Borobia, D. Podzamczer, Á. Soriano, 2021, The Lancet. Infectious diseases.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, M. Bodro, 2021, Revista Española de Quimioterapia.

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

Felipe García, Á. Soriano, M. Laguno, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.

D. Podzamczer, B. Clotet, A. Winston, 2020, The Journal of antimicrobial chemotherapy.

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

J. Miro, J. Mallolas, E. Martinez, 2022, AIDS.

Effects of Different Antigenic Stimuli on Thymic Function and Interleukin-7/CD127 System in Patients with Chronic HIV Infection

Felipe García, M. Plana, T. Pumarola, 2014, Journal of acquired immune deficiency syndromes.

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Á. Soriano, J. Mallolas, J. Blanco, 2023, Infectious Diseases and Therapy.

Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.

J. Mallolas, J. Blanco, M. Laguno, 2023, The Journal of antimicrobial chemotherapy.

Subclinical cardiovascular disease in patients starting contemporary protease inhibitors

J. Mallolas, M. Loncá, M. Camafort, 2018, HIV medicine.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, M. Bodro, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Predictive Factors for HIV Seroconversion Among Individuals Attending a Specialized Center After an HIV Risk Exposure: A Case–Control Study

J. Gatell, A. León, L. Leal, 2016 .

Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.

J. Mallolas, M. Laguno, J. Ambrosioni, 2023, The Journal of antimicrobial chemotherapy.

Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study

J. Miro, E. Fernández, J. Mallolas, 2022, Medicine.